Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
State Policy
Maine Updates Their Gift to Physicians Law Online
Maine has posted a revised version of their gifts to physicians law which bans cash payments from pharmaceutical manufacturers,…
Nevada Proposes Drug Transparency Regulations
We have written many times on the Nevada law passed in Summer 2017 that requires patient advocacy organizations to report all…
New Jersey Finalizes “Gift” Ban of Physicians Working with the…
In an unusual administrative move – without passing any new laws – on December 22, 2017, the Attorney General of New Jersey…
PhRMA Challenges California SB17 in Federal Court
On December 8, 2017, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed a complaint in the United States…
Vermont AG Probing Pharma and Physician Relationships
The Vermont attorney general is investigating the extent to which drug and device makers may have violated state law by giving…
UPDATE: Round 2 with Ohio’s Drug Sample Verification Requirements
In the September issue of the Life Science Compliance Update, the authors discussed the new Ohio drug distribution verification…
New Jersey “Gift” Ban Next Step – Public Hearing on…
Pictured from left to right: Sharon M. Joyce, Acting Director, Division of Consumer Affairs; Christopher S. Porrino, Attorney…
Florida Governor Proposes Limit on Prescribed Opioids
At the end of September, Florida Governor Rick Scott announced that during the upcoming legislative session, he will propose new…
What California’s New Drug Transparency Law Does – And Doesn’t – Do
We have written numerous times on the transparency bills in various states. California’s Senate Bill 17 is one of those bills that…
California Bans Prescription Discounts with Generic Equivalents
The California Assembly and Senate recently passed AB265, focused on amending price discounts permitted on prescription drugs. The…